Thank you, operator, and welcome to DexCom's Third Quarter 2025 Earnings Call. Our agenda begins with Jake Leach, DexCom's President and Interim CEO, who will summarize our recent highlights and ...
SAN DIEGO (AP) — SAN DIEGO (AP) — DexCom Inc. (DXCM) on Thursday reported third-quarter net income of $283.8 million. The San Diego-based company said it had net income of 70 cents per share. Earnings ...
The MarketWatch News Department was not involved in the creation of this content. New dating safety app turns painful experience into a mission to protect others from manipulation, deception, and ...
New dating safety app turns painful experience into a mission to protect others from manipulation, deception, and emotional harm. TAMPA, Fla., Oct. 21, 2025 /PRNewswire/ -- Cray App, LLC today ...
Instagram is exploring building a dedicated TV app as part of a deeper push into video, a move that could get Instagram videos in front of more viewers and also provide more competition for YouTube, ...
Fans in London for today's Vikings-Browns game complained of long queues to get into the stadium and ticketing apps that weren't working. The Daily Mail reports that the OnePass ticketing app wasn’t ...
We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. DexCom, Inc. is one of them. DexCom, Inc. (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM) ...
Fintel reports that on September 26, 2025, Baird maintained coverage of DexCom (NasdaqGS:DXCM) with a Outperform recommendation. Analyst Price Forecast Suggests 54.31% Upside As of September 13, 2025, ...
Google’s AI note-taking and research assistant NotebookLM took off to a spectacular reception at launch, capturing people’s imaginations with its ability to quickly whip up summaries and reports, and ...
SANTA ANA, Calif. – Moment of Clarity has announced the introduction of Operation Clarity at its Santa Ana facility, a new program designed to provide structured, personalized outpatient care with a ...
The Royal College of Psychiatrists in the U.K. has published its first-ever guidance to support research into psychedelic drugs as therapies for conditions including treatment-resistant depression, ...